These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35170859)
1. Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early-stage large-cell neuroendocrine carcinoma. Andreetti C; Ibrahim M; Gagliardi A; Poggi C; Maurizi G; Armillotta D; Peritone V; Teodonio L; Rendina EA; Venuta F; Anile M; Natale G; Santini M; Fiorelli A Thorac Cancer; 2022 Apr; 13(7):900-912. PubMed ID: 35170859 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy. Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090 [TBL] [Abstract][Full Text] [Related]
3. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy. Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636 [TBL] [Abstract][Full Text] [Related]
4. Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma. Wakeam E; Adibfar A; Stokes S; Leighl NB; Giuliani ME; Varghese TK; Darling GE J Thorac Cardiovasc Surg; 2020 May; 159(5):2043-2054.e9. PubMed ID: 31759623 [TBL] [Abstract][Full Text] [Related]
5. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung. Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287 [TBL] [Abstract][Full Text] [Related]
6. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Veronesi G; Morandi U; Alloisio M; Terzi A; Cardillo G; Filosso P; Rea F; Facciolo F; Pelosi G; Gandini S; Calabrò F; Casali C; Marulli G; Spaggiari L Lung Cancer; 2006 Jul; 53(1):111-5. PubMed ID: 16697073 [TBL] [Abstract][Full Text] [Related]
8. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study. Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086 [TBL] [Abstract][Full Text] [Related]
9. Sublobar resection is associated with decreased survival for patients with early stage large-cell neuroendocrine carcinoma of the lung. Lutfi W; Schuchert MJ; Dhupar R; Sarkaria I; Christie NA; Yang CJ; Deng JZ; Luketich JD; Okusanya OT Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):517-524. PubMed ID: 31177277 [TBL] [Abstract][Full Text] [Related]
10. Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study. Xie S; Song L; Yang F; Tang C; Yang S; He J; Pan X Medicine (Baltimore); 2017 Mar; 96(11):e6361. PubMed ID: 28296773 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer). Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951 [TBL] [Abstract][Full Text] [Related]
13. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression. Wertzel H; Grahmann PR; Bansbach S; Lange W; Hasse J; Böhm N Eur J Cardiothorac Surg; 1997 Nov; 12(5):698-702. PubMed ID: 9458138 [TBL] [Abstract][Full Text] [Related]
14. DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC. Ogawa H; Sakai Y; Nishio W; Fujibayashi Y; Nishikubo M; Nishioka Y; Tane S; Kitamura Y; Sudo T; Sakuma T; Yoshimura M Thorac Cancer; 2020 Sep; 11(9):2561-2569. PubMed ID: 32691982 [TBL] [Abstract][Full Text] [Related]
15. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma. Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955 [TBL] [Abstract][Full Text] [Related]
17. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases. Lan-Fang L; Hai-Yan S; Zuo-Ming Y; Jian-Qing Z; Ya-Qing C Eur J Gynaecol Oncol; 2012; 33(1):68-73. PubMed ID: 22439409 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant Chemotherapy Following Surgical Resection Improves Survival in Patients With Early Stage Small Cell Lung Cancer. Yao Y; Zhou Y; Yang Z; Huang H; Shen H Oncol Res; 2019 Feb; 27(2):203-210. PubMed ID: 29523217 [TBL] [Abstract][Full Text] [Related]